Literature DB >> 17570602

Acrolein induces selective protein carbonylation in synaptosomes.

C F Mello1, R Sultana, M Piroddi, J Cai, W M Pierce, J B Klein, D A Butterfield.   

Abstract

Acrolein, the most reactive of the alpha,beta-unsaturated aldehydes, is endogenously produced by lipid peroxidation, and has been found increased in the brain of patients with Alzheimer's disease. Although it is known that acrolein increases total protein carbonylation and impairs the function of selected proteins, no study has addressed which proteins are selectively carbonylated by this aldehyde. In this study we investigated the effect of increasing concentrations of acrolein (0, 0.005, 0.05, 0.5, 5, 50 microM) on protein carbonylation in gerbil synaptosomes. In addition, we applied proteomics to identify synaptosomal proteins that were selectively carbonylated by 0.5 microM acrolein. Acrolein increased total protein carbonylation in a dose-dependent manner. Proteomic analysis (two-dimensional electrophoresis followed by mass spectrometry) revealed that tropomyosin-3-gamma isoform 2, tropomyosin-5, beta-actin, mitochondrial Tu translation elongation factor (EF-Tu(mt)) and voltage-dependent anion channel (VDAC) were significantly carbonylated by acrolein. Consistent with the proteomics studies that have identified specifically oxidized proteins in Alzheimer's disease (AD) brain, the proteins identified in this study are involved in a wide variety of cellular functions including energy metabolism, neurotransmission, protein synthesis, and cytoskeletal integrity. Our results suggest that acrolein may significantly contribute to oxidative damage in AD brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570602      PMCID: PMC1987324          DOI: 10.1016/j.neuroscience.2007.04.003

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  44 in total

1.  Protein oxidation in the brain in Alzheimer's disease.

Authors:  M Y Aksenov; M V Aksenova; D A Butterfield; J W Geddes; W R Markesbery
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.

Authors:  M A Lovell; C Xie; W R Markesbery
Journal:  Free Radic Biol Med       Date:  2000-10-15       Impact factor: 7.376

Review 3.  The voltage-dependent anion channel: an essential player in apoptosis.

Authors:  Yoshihide Tsujimoto; Shigeomi Shimizu
Journal:  Biochimie       Date:  2002 Feb-Mar       Impact factor: 4.079

Review 4.  Current status of acrolein as a lipid peroxidation product.

Authors:  K Uchida
Journal:  Trends Cardiovasc Med       Date:  1999-07       Impact factor: 6.677

5.  Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease.

Authors:  C B Pocernich; A L Cardin; C L Racine; C M Lauderback; D A Butterfield
Journal:  Neurochem Int       Date:  2001-08       Impact factor: 3.921

6.  Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.

Authors:  M A Lovell; C Xie; W R Markesbery
Journal:  Neurobiol Aging       Date:  2001 Mar-Apr       Impact factor: 4.673

Review 7.  Mitochondrial membrane permeability transition and cell death.

Authors:  Yoshihide Tsujimoto; Takashi Nakagawa; Shigeomi Shimizu
Journal:  Biochim Biophys Acta       Date:  2006-04-19

8.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 9.  Lipid peroxidation in aging brain and Alzheimer's disease.

Authors:  Thomas J Montine; M Diana Neely; Joseph F Quinn; M Flint Beal; William R Markesbery; L Jackson Roberts; Jason D Morrow
Journal:  Free Radic Biol Med       Date:  2002-09-01       Impact factor: 7.376

10.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

Authors:  Alessandra Castegna; Michael Aksenov; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

View more
  21 in total

Review 1.  Chemical probes for analysis of carbonylated proteins: a review.

Authors:  Liang-Jun Yan; Michael J Forster
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-08-07       Impact factor: 3.205

2.  Proteomic profiling of rat lung epithelial cells induced by acrolein.

Authors:  Poonam Sarkar; Barbara E Hayes
Journal:  Life Sci       Date:  2009-05-30       Impact factor: 5.037

3.  Proteomic profiling of acrolein adducts in human lung epithelial cells.

Authors:  Page C Spiess; Bin Deng; Robert J Hondal; Dwight E Matthews; Albert van der Vliet
Journal:  J Proteomics       Date:  2011-06-17       Impact factor: 4.044

4.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

5.  Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity.

Authors:  Mubeen A Ansari; Jeffrey N Keller; Stephen W Scheff
Journal:  Free Radic Biol Med       Date:  2008-09-09       Impact factor: 7.376

Review 6.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

7.  Hop proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species.

Authors:  Woon-Gye Chung; Cristobal L Miranda; Jan F Stevens; Claudia S Maier
Journal:  Food Chem Toxicol       Date:  2009-04       Impact factor: 6.023

Review 8.  Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.

Authors:  Isidre Ferrer
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

9.  VDAC1: from structure to cancer therapy.

Authors:  Varda Shoshan-Barmatz; Dario Mizrachi
Journal:  Front Oncol       Date:  2012-11-29       Impact factor: 6.244

10.  TPM3 and TPM4 gene products segregate to the postsynaptic region of central nervous system synapses.

Authors:  Kim Guven; Peter Gunning; Thomas Fath
Journal:  Bioarchitecture       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.